The Effect of Impaired Glucagon Suppression in Pre-diabetes
Tab Title Description
Describes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
- Rochester, Minnesota: 16-009852
Sponsor Protocol Number: 16-009852
About this study
The purpose of this study is to determine the effect of impaired postprandial glucagon suppression on postprandial glucose metabolism.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
- Subjects will be recruited from prior participation in studies specifically designed to correlate genotype with phenotype. We plan to contact prior participants by means of IRB-approved letters. Eligible subjects will be invited to participate in the study and to come to the CRU for a screening visit
- Medications that can affect glucose metabolism (to be determined by PI)
- For female subjects: positive pregnancy test
- Any active systemic illness, microvascular or macrovascular disease
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
|Mayo Clinic Location
Mayo Clinic principal investigator
Adrian Vella, M.D.
Closed for enrollment
Publications are currently not available
Study Results Summary
Not yet available
Supplemental Study Information
Not yet available